• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

受体蛋白酪氨酸激酶EphB4在子宫内膜增生和子宫内膜癌中的激活。

Activation of the receptor protein tyrosine kinase EphB4 in endometrial hyperplasia and endometrial carcinoma.

作者信息

Berclaz G, Karamitopoulou E, Mazzucchelli L, Rohrbach V, Dreher E, Ziemiecki A, Andres A-C

机构信息

Department of Obstetrics and Gynecology, University Hospital, Berne, Switzerland.

出版信息

Ann Oncol. 2003 Feb;14(2):220-6. doi: 10.1093/annonc/mdg072.

DOI:10.1093/annonc/mdg072
PMID:12562648
Abstract

BACKGROUND

Members of the Eph family of tyrosine kinases have been implicated in embryonic pattern formation and vascular development; however, little is known about their role in the adult organism. We have observed estrogen-dependent EphB4 expression in the normal breast suggesting its implication in the hormone-controlled homeostasis of this organ. Since the endometrium is a similarly hormone dependent organ and endometrial carcinoma is thought to result from estrogenic stimulation, we have investigated EphB4 expression in normal human endometrium and during its carcinogenesis.

PATIENTS AND METHODS

EphB4 expression was analyzed immunohistochemically in 26 normal endometrium specimens, 15 hyperplasias and 102 endometrioid adenocarcinomas and correlated with clinical and prognostic tumor characteristics.

RESULTS

In normal endometrial tissue no EphB4 protein was detected. Strikingly, we observed a drastic increase (P <0.0001) in the number of EphB4 protein-expressing glandular epithelial cells in the majority of hyperplasias and carcinomas. Moreover, we found a statistically highly significant positive correlation between EphB4 expression and post-menopausal stage of the patient (P = 0.007).

CONCLUSIONS

These findings indicate that in the endometrium, EphB4 is an early indicator of malignant development and, thus, EphB4 may represent a potent tool for diagnosis and therapeutic intervention.

摘要

背景

酪氨酸激酶Eph家族成员已被证实参与胚胎模式形成和血管发育;然而,它们在成体中的作用却鲜为人知。我们观察到在正常乳腺中存在雌激素依赖性的EphB4表达,提示其参与该器官的激素调控稳态。由于子宫内膜是一个同样依赖激素的器官,且子宫内膜癌被认为是由雌激素刺激所致,我们研究了EphB4在正常人类子宫内膜及其癌变过程中的表达。

患者和方法

采用免疫组织化学方法分析了26例正常子宫内膜标本、15例增生组织和102例子宫内膜样腺癌中EphB4的表达,并将其与临床和肿瘤预后特征进行关联分析。

结果

在正常子宫内膜组织中未检测到EphB4蛋白。令人惊讶的是,我们观察到在大多数增生组织和癌组织中,表达EphB4蛋白的腺上皮细胞数量急剧增加(P <0.0001)。此外,我们发现EphB4表达与患者绝经后阶段之间存在统计学上高度显著的正相关(P = 0.007)。

结论

这些发现表明,在子宫内膜中,EphB4是恶性发展的早期指标,因此,EphB4可能是一种有效的诊断和治疗干预工具。

相似文献

1
Activation of the receptor protein tyrosine kinase EphB4 in endometrial hyperplasia and endometrial carcinoma.受体蛋白酪氨酸激酶EphB4在子宫内膜增生和子宫内膜癌中的激活。
Ann Oncol. 2003 Feb;14(2):220-6. doi: 10.1093/annonc/mdg072.
2
Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and Ki-67 expression.类固醇受体共激活因子和共抑制因子在人子宫内膜增生和癌中的表达及其与类固醇受体和Ki-67表达的相关性
Cancer. 2003 Nov 15;98(10):2207-13. doi: 10.1002/cncr.11760.
3
Loss of EphB4 receptor tyrosine kinase protein expression during carcinogenesis of the human breast.人乳腺癌发生过程中EphB4受体酪氨酸激酶蛋白表达缺失
Oncol Rep. 2002 Sep-Oct;9(5):985-9.
4
Overexpression of ephrinB2 and EphB4 in tumor advancement of uterine endometrial cancers.EphrinB2和EphB4在子宫内膜癌肿瘤进展中的过表达
Ann Oncol. 2007 Mar;18(3):485-90. doi: 10.1093/annonc/mdl414. Epub 2006 Nov 15.
5
Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium.子宫内膜癌中CD24表达增强及其在正常和增生期子宫内膜中的表达模式。
Histol Histopathol. 2009 Mar;24(3):309-16. doi: 10.14670/HH-24.309.
6
Expression of receptor tyrosine kinase EphB4 and its ligand ephrin-B2 is associated with malignant potential in endometrial cancer.受体酪氨酸激酶EphB4及其配体ephrin - B2的表达与子宫内膜癌的恶性潜能相关。
Oncol Rep. 2001 May-Jun;8(3):567-73. doi: 10.3892/or.8.3.567.
7
Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma.成年干细胞标志物Musashi-1在子宫内膜异位症和子宫内膜癌中的表达增加。
J Pathol. 2008 Jul;215(3):317-29. doi: 10.1002/path.2364.
8
Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.视网膜母细胞瘤相关基因Rb2/p130在非典型子宫内膜增生和腺癌中的表达下调。
Hum Pathol. 2001 Apr;32(4):360-7. doi: 10.1053/hupa.2001.23514.
9
Apoptosis-related proteins and steroid hormone receptors in normal, hyperplastic, and neoplastic endometrium.正常、增生及肿瘤性子宫内膜中的凋亡相关蛋白和甾体激素受体
Int J Gynecol Pathol. 2002 Oct;21(4):375-82. doi: 10.1097/00004347-200210000-00007.
10
Expression of p53, Bcl-2 and Bax in endometrial carcinoma, endometrial hyperplasia and normal endometrium: a histopathological study.p53、Bcl-2和Bax在子宫内膜癌、子宫内膜增生及正常子宫内膜中的表达:一项组织病理学研究
J Obstet Gynaecol. 2018 Oct;38(7):999-1004. doi: 10.1080/01443615.2018.1437717. Epub 2018 Mar 21.

引用本文的文献

1
Identification of potent pan-ephrin receptor kinase inhibitors using DNA-encoded chemistry technology.利用DNA编码化学技术鉴定有效的泛肾上腺素受体激酶抑制剂。
Proc Natl Acad Sci U S A. 2024 May 7;121(19):e2322934121. doi: 10.1073/pnas.2322934121. Epub 2024 May 3.
2
The EPH/Ephrin System in Gynecological Cancers: Focusing on the Roots of Carcinogenesis for Better Patient Management.妇科癌症中的 Eph/Ephrin 系统:关注癌症发生的根源以更好地管理患者。
Int J Mol Sci. 2022 Mar 17;23(6):3249. doi: 10.3390/ijms23063249.
3
Overexpression of Receptor Tyrosine Kinase EphB4 Triggers Tumor Growth and Hypoxia in A375 Melanoma Xenografts: Insights from Multitracer Small Animal Imaging Experiments.
EphB4 受体酪氨酸激酶过表达触发 A375 黑色素瘤异种移植瘤的肿瘤生长和缺氧:来自多示踪剂小动物成像实验的见解。
Molecules. 2018 Feb 17;23(2):444. doi: 10.3390/molecules23020444.
4
The role of EphB4 and IGF-IR expression in breast cancer cells.EphB4和胰岛素样生长因子-1受体(IGF-IR)表达在乳腺癌细胞中的作用。
Int J Clin Exp Pathol. 2015 May 1;8(5):5997-6004. eCollection 2015.
5
Expression of the EPHB4 receptor tyrosine kinase in head and neck and renal malignancies--implications for solid tumors and potential for therapeutic inhibition.EPHB4受体酪氨酸激酶在头颈部及肾脏恶性肿瘤中的表达——对实体瘤的意义及治疗性抑制的潜力
Growth Factors. 2014 Dec;32(6):202-6. doi: 10.3109/08977194.2014.980904. Epub 2014 Nov 13.
6
EphB4 regulates the growth and migration of pancreatic cancer cells.EphB4调节胰腺癌细胞的生长和迁移。
Tumour Biol. 2014 Jul;35(7):6855-9. doi: 10.1007/s13277-014-1937-6. Epub 2014 Apr 15.
7
Therapeutic targeting of EPH receptors and their ligands.EPH 受体及其配体的治疗靶向。
Nat Rev Drug Discov. 2014 Jan;13(1):39-62. doi: 10.1038/nrd4175.
8
EphB4-targeted imaging with antibody h131, h131-F(ab')2 and h131-Fab.EphB4 靶向成像抗体 h131、h131-F(ab')2 和 h131-Fab。
Mol Pharm. 2013 Dec 2;10(12):4527-33. doi: 10.1021/mp400354y. Epub 2013 Nov 7.
9
Array-based profiling of the differential methylation status of CpG islands in hepatocellular carcinoma cell lines.基于芯片技术分析肝癌细胞系中CpG岛的差异甲基化状态
Oncol Lett. 2010 Sep;1(5):815-820. doi: 10.3892/ol_00000143. Epub 2010 Sep 1.
10
Clinical relevance of Ephs and ephrins in cancer: lessons from breast, colorectal, and lung cancer profiling.Eph 及其配体在癌症中的临床相关性:从乳腺癌、结直肠癌和肺癌的分析中得到的启示。
Semin Cell Dev Biol. 2012 Feb;23(1):102-8. doi: 10.1016/j.semcdb.2011.10.014. Epub 2011 Oct 21.